Nirogy Therapeutics Launches with $16.5 Million Series A Financing

NEXT STORY
Antibody Testing Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product ; Indication ; End-User, and Geography.
PREV STORY
CloudMD to Acquire Rxi Group of Companies, an Established One-Stop Patient Support Logistics Company and Leading Customer Relationship Management Technology Provider
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biota Pharmaceuticals Appoints Armando Anido and Michael Dunne, M.D. to Its Board of Directors

ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a ...

author_avatar
NASDAQ Market News

RENNOVA HEALTH COMPLETES PURCHASE OF AN EIGHTY FIVE BED ACUTE CARE HOSPITAL IN JAMESTOWN, TN.

West Palm Beach, Fla., June 01, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: ...

author_avatar
NASDAQ Market News

Melinta Therapeutics Receives Up to $6.2 Million from CARB-X to Advance Clinical Development of a Novel Antimicrobial to Combat Antibiotic-Resistant Bacteria

NEW HAVEN, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a ...

author_avatar
NASDAQ Market News